Developer docs
API playgroundTry for free, no card

Search company profiles

National Breast Cancer Coalition

Full company profile

uuid0025ny9

Namestring
National Breast Cancer Coalition
Legal namestring
National Breast Cancer Coalition and Fund
Company typeenum
Private
Founded yearint
1991
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersWashington, United States
HQ citystring
Washington
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
breast cancer advocacy, cancer research funding, patient advocacy training, public policy advocacy, nonprofit health advocacy
Industry3 codes
1Public Health & Health Equity Organizations
CodeBPAGACALPrimaryYes
2Global Immunization & Vaccine Access Alliances
CodeHLAJAKAKPrimaryNo
3Community Health, Prevention & Health Education
CodeBPAGACACPrimaryNo
NAICS code2 codes
  • Other Social Advocacy Organizations813319
  • Social Advocacy Organizations81331
SIC code2 codes
  • Services-Social Services8300
  • Services-Membership Organizations8600
Product category
Nonprofit Health Advocacy
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model5 records
1Individual Donations and Membership
TypeSubscription Recurring
Description

NBCC receives donations from individuals, including membership fees. The President's Council offers membership at $1,000+ annually with special benefits including direct communications from the President.

stopbreastcancer.org
2Event Fundraising
TypeOne Time License
Description

Revenue generated from signature events including Les Girls Cabaret and Women With Balls bowling events. Corporate sponsorships and team registrations for events provide additional fundraising opportunities.

stopbreastcancer.org
3Corporate and Foundation Grants
TypeProfessional Services
Description

Support from foundations such as the National Philanthropic Trust for specific programs and general purposes. Corporate partners provide grants, donations, event sponsorships, and cause-related marketing partnerships.

stopbreastcancer.org
4Workplace Giving
TypeSubscription Recurring
Description

Combined Federal Campaign #12193 allows employees to designate NBCC through workplace giving programs, including payroll deductions.

stopbreastcancer.org
5Planned and Legacy Gifts
TypeLicensing Royalties
Description

Planned giving options including retirement plan beneficiary designations, estate planning bequests, charitable gift annuities, and charitable remainder trusts.

stopbreastcancer.org
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Others
Pricing details4 tiers
1Standard Membership - Donation-based support
ModelSubscriptionBilling cadenceAnnual
Notes

Individual membership fees; specific amounts not publicly disclosed

stopbreastcancer.org
2President's Council - Premium membership tier
ModelSubscriptionBilling cadenceAnnual
Notes

$1,000 or more annually; includes direct communications from Fran Visco, recognition in publications, and invitations to special events

stopbreastcancer.org
3Women With Balls Event - Team Registration
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Private lane (8 bowlers): $3,600; Shared lane (4 bowlers): $1,800; Individual placement: $450

stopbreastcancer.org
4Women With Balls Event Sponsorships
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Sponsorships start at $2,500

stopbreastcancer.org
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 record
1Artemis Project®
Description

An advocate-led collaboration of researchers and advocates developing research action plans to address primary prevention and prevention of metastasis in breast cancer.

stopbreastcancer.org
Core offering1 text field

National Breast Cancer Coalition (NBCC) is a 501(c)(3) nonprofit advocacy organization that mobilizes survivors, researchers, and policymakers to end breast cancer through grassroots advocacy, public policy campaigns, and collaborative research. Its core offerings include the Artemis Project® (advocate-led research initiative developing a preventive breast cancer vaccine), Project LEAD (science and advocacy training), the annual Advocate Leadership Summit, and legislative campaigns such as the Metastatic Breast Cancer Access to Care Act.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Over $4 billion in federal breast cancer research funding secured through advocacy
+3 more records
Product overview1 text field

National Breast Cancer Coalition is a non-profit advocacy organization that links hundreds of organizations and tens of thousands of individuals to end breast cancer. The organization's offerings include the Artemis Project® (advocate-led research initiative for breast cancer prevention and metastasis prevention, including a preventive vaccine in Phase I trial), Project LEAD (advocacy training), the annual Advocate Leadership Summit (educational conference), Breast Cancer Deadline 2020® (research initiative), and policy advocacy programs including the Metastatic Breast Cancer Access to Care Act campaign. The organization also provides an Information Center with educational resources, and hosts fundraising events including Les Girls Cabaret and Women With Balls®.

Product and service8 records
1Artemis Project®
CategoryResearch initiative
Description

An advocate-led collaboration of researchers and advocates that develops and implements research action plans to address primary prevention and prevention of metastasis in breast cancer, including a preventive breast cancer vaccine in partnership with NCI PREVENT and Mayo Clinic, with Phase I clinical trials planned for 2025.

2Project LEAD
CategoryEducation and training program
Description

NBCC's science and advocacy training program that prepares advocates to work alongside scientists, policy makers, and health care providers in research and policy decision-making.

3Advocate Leadership Summit
CategoryEducation and training program
Description

Annual gathering of breast cancer advocates from across the country and around the world, featuring sessions on the latest scientific research, advocacy training, and presentations by researchers and public policy experts.

4Metastatic Breast Cancer Access to Care Act Campaign
CategoryPolicy advocacy program
Description

NBCC's legislative campaign to pass legislation that would waive the 24-month waiting period for Medicare and 5-month waiting period for Social Security Disability Insurance benefits for eligible individuals with metastatic breast cancer.

5Les Girls Cabaret
CategoryFundraising event
Description

NBCC's signature Hollywood fundraising event bringing together advocates, corporate sponsors, and supporters to raise funds and awareness for breast cancer advocacy.

6Women With Balls®
CategoryFundraising event
Description

NBCC's annual NYC bowling fundraising event with team registration options including Private lane (8 bowlers) at $3,600, Shared lane (4 bowlers) at $1,800, and Individual placement at $450. Sponsorships start at $2,500.

7Information Center
CategoryEducational resource
Description

Online resource center providing breast cancer facts, figures, myths and truths, legislative priorities, science education, and a video library for advocates and the public.

8NBCC Membership Program
CategoryMembership program
Description

Annual membership program with a standard membership tier (donation-based) and a President's Council premium tier at $1,000+ annually that includes direct communications from the President, recognition in publications, and invitations to special events.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

NCI PREVENT is a peer-reviewed agent development program supporting the pre-clinical development of innovative interventions for cancer prevention. NBCC's Artemis Project Preventive Vaccine was awarded a contract with NCI PREVENT in 2020 to advance the preventive vaccine through preclinical development toward clinical trials.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Mayo Clinic, specifically Dr. Keith Knutson, Professor of Immunology, is conducting pre-clinical work on the Artemis Project preventive vaccine. NBCC partnered with Mayo Clinic for Phase I trial planned to launch in 2025.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

NBCC partnered with the New York Genome Center to develop DNA.Land, a large-scale resource to study breast cancer by collecting genomic data and breast cancer questionnaire responses from participants.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

NBCC President Fran Visco serves on the board of directors of this international non-profit clinical trials consortium.

5Dr. Cyrus Ghajar - Fred Hutchinson Cancer Center
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Received Artemis Project seed grant to investigate adaptive immune recognition of dormant disseminated tumor cells, focusing on how to prevent metastasis.

stopbreastcancer.org
6Dr. H. Kim Lyerly - Duke University School of Medicine
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Multiple Artemis Project collaborations including DCIS vaccine target research and dormant tumor cell studies.

stopbreastcancer.org
7Dr. Gregory Hannon - Cold Spring Harbor Laboratory
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Received $325,000 grant to evaluate the biology of human DCIS through next-generation sequencing for vaccine target identification.

stopbreastcancer.org
Strategic tierMajorTypeTechnology or Integration
Description

NBCC partnered with GW's Computational Genomics and Bioinformatics division and Center for Biomedical Informatics to host DNA.Land data on GW's cloud-based platform (GW-FEAST).

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

A patient-led cancer advocacy organization focused on policy and survivorship issues. Directly comparable to NBCC as a cancer-focused, survivor-driven policy advocacy nonprofit operating at the federal level.

TypeDirect peer
Description

The largest breast cancer-focused nonprofit in the U.S., also funding research, advocacy, and patient support. Directly comparable to NBCC in mission and constituency, though Komen operates at much larger scale with both research funding and direct service programs.

TypeRegional player
Description

A cancer-specific nonprofit focused on ovarian cancer advocacy, awareness, and research. Adjacent comparable as another leading women's cancer coalition, useful as a model of single-disease coalition organizing but operating in a different cancer category.

TypeDirect peer
Description

A breast cancer-focused nonprofit supporting patients through education, resources, and community. Directly comparable as a smaller breast cancer advocacy nonprofit with overlapping audience but with more direct-service programming.

TypeEmerging player
Description

A breast cancer-focused nonprofit addressing disparities, particularly for Black women (NBCC has cited the 40% mortality gap among Black women). Comparable as a smaller, advocacy and equity-focused peer organization with overlap on disparities and policy.

TypeBroad incumbent
Description

A high-profile cancer research fundraising collaborative focused on accelerating cancer research. Comparable as a research-advocacy nonprofit leveraging celebrity and media engagement, but operates with different funding mechanisms (translational research teams).

TypeDirect peer
Description

A national nonprofit focused on cancer prevention and early detection through research, education, and advocacy. NBCC's Artemis Project prevention focus and federal policy engagement position it as a strong direct peer.

TypeBroad incumbent
Description

The largest and most established U.S. cancer nonprofit with broad research, advocacy, and patient services across all cancer types. Comparable as the dominant incumbent in cancer advocacy, though at materially larger scale and with a broader non-breast-cancer mandate.

TypeDirect peer
Description

A breast cancer-focused advocacy nonprofit with a similar patient-advocacy and policy reform mission. Directly comparable as a smaller, advocacy-led breast cancer organization with strong accountability positioning.

TypeEmerging player
Description

A professional scientific organization that funds cancer research and advocates for federal research funding. AACR awarded Fran Visco its Outstanding Achievement Award; comparable as a research-advocacy organization but research-led rather than survivor-led.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

National Breast Cancer Coalition

Nonprofit Health Advocacystopbreastcancer.org

National Breast Cancer Coalition firmographics

Firmographics
Name
National Breast Cancer Coalition
Legal name
National Breast Cancer Coalition and Fund
Website
https://stopbreastcancer.org
Company type
Private
Founded year
1991
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

National Breast Cancer Coalition industry classification

Industry
Product category
Nonprofit Health Advocacy
NAICS
Other Social Advocacy Organizations (813319), Social Advocacy Organizations (81331)
SIC
Services-Social Services (8300), Services-Membership Organizations (8600)
akta.pro primary industry
Public Health & Health Equity Organizations (BPAGACAL)
akta.pro secondary industries
Global Immunization & Vaccine Access Alliances (HLAJAKAK), Community Health, Prevention & Health Education (BPAGACAC)

Keywords

  • Breast cancer advocacy
  • Cancer research funding
  • Patient advocacy training
  • Public policy advocacy
  • Nonprofit health advocacy

Where National Breast Cancer Coalition is headquartered

Location

Headquarters

HQ city
Washington
HQ country
United States
HQ region
North America

Offices1 record

Markets served

National Breast Cancer Coalition business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Individual Donations and Membership: NBCC receives donations from individuals, including membership fees. The President's Council offers membership at $1,000+ annually with special benefits including direct communications from the President.
  2. Event Fundraising: Revenue generated from signature events including Les Girls Cabaret and Women With Balls bowling events. Corporate sponsorships and team registrations for events provide additional fundraising opportunities.
  3. Corporate and Foundation Grants: Support from foundations such as the National Philanthropic Trust for specific programs and general purposes. Corporate partners provide grants, donations, event sponsorships, and cause-related marketing partnerships.
  4. Workplace Giving: Combined Federal Campaign #12193 allows employees to designate NBCC through workplace giving programs, including payroll deductions.
  5. Planned and Legacy Gifts: Planned giving options including retirement plan beneficiary designations, estate planning bequests, charitable gift annuities, and charitable remainder trusts.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualStandard Membership - Donation-based support
SubscriptionAnnualPresident's Council - Premium membership tier
One time/ perpetual licensePay-as-you-goWomen With Balls Event - Team Registration
One time/ perpetual licensePay-as-you-goWomen With Balls Event Sponsorships

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

National Breast Cancer Coalition product offering

Product offering

Core offering

National Breast Cancer Coalition (NBCC) is a 501(c)(3) nonprofit advocacy organization that mobilizes survivors, researchers, and policymakers to end breast cancer through grassroots advocacy, public policy campaigns, and collaborative research. Its core offerings include the Artemis Project® (advocate-led research initiative developing a preventive breast cancer vaccine), Project LEAD (science and advocacy training), the annual Advocate Leadership Summit, and legislative campaigns such as the Metastatic Breast Cancer Access to Care Act.

Product overview

National Breast Cancer Coalition is a non-profit advocacy organization that links hundreds of organizations and tens of thousands of individuals to end breast cancer. The organization's offerings include the Artemis Project® (advocate-led research initiative for breast cancer prevention and metastasis prevention, including a preventive vaccine in Phase I trial), Project LEAD (advocacy training), the annual Advocate Leadership Summit (educational conference), Breast Cancer Deadline 2020® (research initiative), and policy advocacy programs including the Metastatic Breast Cancer Access to Care Act campaign. The organization also provides an Information Center with educational resources, and hosts fundraising events including Les Girls Cabaret and Women With Balls®.

Differentiator

Problem solved

Functional benefit

Brands

  • Artemis Project®: An advocate-led collaboration of researchers and advocates developing research action plans to address primary prevention and prevention of metastasis in breast cancer.

Products and services

  • Artemis Project® An advocate-led collaboration of researchers and advocates that develops and implements research action plans to address primary prevention and prevention of metastasis in breast cancer, including a preventive breast cancer vaccine in partnership with NCI PREVENT and Mayo Clinic, with Phase I clinical trials planned for 2025.
  • Project LEAD NBCC's science and advocacy training program that prepares advocates to work alongside scientists, policy makers, and health care providers in research and policy decision-making.
  • Advocate Leadership Summit Annual gathering of breast cancer advocates from across the country and around the world, featuring sessions on the latest scientific research, advocacy training, and presentations by researchers and public policy experts.
  • Metastatic Breast Cancer Access to Care Act Campaign NBCC's legislative campaign to pass legislation that would waive the 24-month waiting period for Medicare and 5-month waiting period for Social Security Disability Insurance benefits for eligible individuals with metastatic breast cancer.
  • Les Girls Cabaret NBCC's signature Hollywood fundraising event bringing together advocates, corporate sponsors, and supporters to raise funds and awareness for breast cancer advocacy.
  • Women With Balls® NBCC's annual NYC bowling fundraising event with team registration options including Private lane (8 bowlers) at $3,600, Shared lane (4 bowlers) at $1,800, and Individual placement at $450. Sponsorships start at $2,500.
  • Information Center Online resource center providing breast cancer facts, figures, myths and truths, legislative priorities, science education, and a video library for advocates and the public.
  • NBCC Membership Program Annual membership program with a standard membership tier (donation-based) and a President's Council premium tier at $1,000+ annually that includes direct communications from the President, recognition in publications, and invitations to special events.

Quantifiable outcome

  • Over $4 billion in federal breast cancer research funding secured through advocacy
  • +3 more outcomes

Companies that use National Breast Cancer Coalition

Customer profile

Named customers6 records

Segments4 records

Ideal customer profiles4 records

National Breast Cancer Coalition technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

National Breast Cancer Coalition partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core, major and minor.

  • National Cancer Institute (NCI) PREVENT ProgramcoreStrategic or Co-development PartnerNCI PREVENT is a peer-reviewed agent development program supporting the pre-clinical development of innovative interventions for cancer prevention. NBCC's Artemis Project Preventive Vaccine was awarded a contract with NCI PREVENT in 2020 to advance the preventive vaccine through preclinical development toward clinical trials.
  • Mayo CliniccoreStrategic or Co-development PartnerMayo Clinic, specifically Dr. Keith Knutson, Professor of Immunology, is conducting pre-clinical work on the Artemis Project preventive vaccine. NBCC partnered with Mayo Clinic for Phase I trial planned to launch in 2025.
  • New York Genome CentermajorStrategic or Co-development PartnerNBCC partnered with the New York Genome Center to develop DNA.Land, a large-scale resource to study breast cancer by collecting genomic data and breast cancer questionnaire responses from participants.
  • Translational Research in OncologyminorStrategic or Co-development PartnerNBCC President Fran Visco serves on the board of directors of this international non-profit clinical trials consortium.
  • Dr. Cyrus Ghajar - Fred Hutchinson Cancer CentermajorStrategic or Co-development PartnerReceived Artemis Project seed grant to investigate adaptive immune recognition of dormant disseminated tumor cells, focusing on how to prevent metastasis.
  • Dr. H. Kim Lyerly - Duke University School of MedicinemajorStrategic or Co-development PartnerMultiple Artemis Project collaborations including DCIS vaccine target research and dormant tumor cell studies.
  • Dr. Gregory Hannon - Cold Spring Harbor LaboratorymajorStrategic or Co-development PartnerReceived $325,000 grant to evaluate the biology of human DCIS through next-generation sequencing for vaccine target identification.
  • George Washington UniversitymajorTechnology or IntegrationNBCC partnered with GW's Computational Genomics and Bioinformatics division and Center for Biomedical Informatics to host DNA.Land data on GW's cloud-based platform (GW-FEAST).

Scale indicators9 records

Recent moves6 records

Expansion highlights5 records

National Breast Cancer Coalition competitors and assessment

Company assessment

Direct peers

  • National Coalition for Cancer Survivorship: A patient-led cancer advocacy organization focused on policy and survivorship issues. Directly comparable to NBCC as a cancer-focused, survivor-driven policy advocacy nonprofit operating at the federal level.
  • Susan G. Komen: The largest breast cancer-focused nonprofit in the U.S., also funding research, advocacy, and patient support. Directly comparable to NBCC in mission and constituency, though Komen operates at much larger scale with both research funding and direct service programs.
  • Living Beyond Breast Cancer: A breast cancer-focused nonprofit supporting patients through education, resources, and community. Directly comparable as a smaller breast cancer advocacy nonprofit with overlapping audience but with more direct-service programming.
  • Prevent Cancer Foundation: A national nonprofit focused on cancer prevention and early detection through research, education, and advocacy. NBCC's Artemis Project prevention focus and federal policy engagement position it as a strong direct peer.
  • Breast Cancer Action: A breast cancer-focused advocacy nonprofit with a similar patient-advocacy and policy reform mission. Directly comparable as a smaller, advocacy-led breast cancer organization with strong accountability positioning.

Regional players

  • National Ovarian Cancer Coalition: A cancer-specific nonprofit focused on ovarian cancer advocacy, awareness, and research. Adjacent comparable as another leading women's cancer coalition, useful as a model of single-disease coalition organizing but operating in a different cancer category.

Emerging players

  • Tigerlily Foundation: A breast cancer-focused nonprofit addressing disparities, particularly for Black women (NBCC has cited the 40% mortality gap among Black women). Comparable as a smaller, advocacy and equity-focused peer organization with overlap on disparities and policy.
  • American Association for Cancer Research (AACR): A professional scientific organization that funds cancer research and advocates for federal research funding. AACR awarded Fran Visco its Outstanding Achievement Award; comparable as a research-advocacy organization but research-led rather than survivor-led.

Broad incumbents

  • Stand Up To Cancer: A high-profile cancer research fundraising collaborative focused on accelerating cancer research. Comparable as a research-advocacy nonprofit leveraging celebrity and media engagement, but operates with different funding mechanisms (translational research teams).
  • American Cancer Society: The largest and most established U.S. cancer nonprofit with broad research, advocacy, and patient services across all cancer types. Comparable as the dominant incumbent in cancer advocacy, though at materially larger scale and with a broader non-breast-cancer mandate.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

National Breast Cancer Coalition social profiles

Digital presence

National Breast Cancer Coalition compliance and trust

Trust signal

Compliance5 records

National Breast Cancer Coalition financial estimates

Financial estimate

Revenue estimate

Valuation estimate

National Breast Cancer Coalition leadership team

Management profile

Number of profiles

Profiles5 records

National Breast Cancer Coalition funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

National Breast Cancer Coalition M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about National Breast Cancer Coalition

What does National Breast Cancer Coalition do?

National Breast Cancer Coalition (NBCC) is a 501(c)(3) nonprofit advocacy organization that mobilizes survivors, researchers, and policymakers to end breast cancer through grassroots advocacy, public policy campaigns, and collaborative research. Its core offerings include the Artemis Project® (advocate-led research initiative developing a preventive breast cancer vaccine), Project LEAD (science and advocacy training), the annual Advocate Leadership Summit, and legislative campaigns such as the Metastatic Breast Cancer Access to Care Act.

Is National Breast Cancer Coalition a public or private company?

National Breast Cancer Coalition is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was National Breast Cancer Coalition founded?

National Breast Cancer Coalition was founded in 1991. It employs 11 to 50 people.

Where is National Breast Cancer Coalition based?

National Breast Cancer Coalition is headquartered in Washington, United States, in the North America region.

How does National Breast Cancer Coalition make money?

Five revenue lines are on record. Individual Donations and Membership is the primary driver. The others are event Fundraising, corporate and Foundation Grants, workplace Giving and planned and Legacy Gifts.

Who are National Breast Cancer Coalition's main competitors?

Direct peers on record are National Coalition for Cancer Survivorship, Susan G. Komen, Living Beyond Breast Cancer, Prevent Cancer Foundation and Breast Cancer Action. National Ovarian Cancer Coalition is listed as a regional player. Emerging players are Tigerlily Foundation and American Association for Cancer Research (AACR). Broad incumbents are Stand Up To Cancer and American Cancer Society.

Does National Breast Cancer Coalition have an API?

No public API is recorded for National Breast Cancer Coalition.

What industry is National Breast Cancer Coalition in?

National Breast Cancer Coalition's product category is Nonprofit Health Advocacy. Its primary akta.pro industry code is BPAGACAL, Public Health & Health Equity Organizations, with a secondary code of HLAJAKAK, Global Immunization & Vaccine Access Alliances. Its NAICS code is 813319 and its SIC code is 8300.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireSusan M. Love, MD, MBA, directora visionaria y "madre fundadora" de la defensa e investigación del cáncer de mama, ha fallecidoDr. Susan M. Love, a pioneering breast cancer surgeon and founder of the Dr. Susan Love Foundation for Breast Cancer Research, has died at age 75 from recurrent leukemia in Los Angeles. She is widely recognized for her advocacy work, including co-founding the National Breast Cancer Coalition and establishing the Love Research Army, which now includes over 390,000 global collaborators. Her legacy includes significant contributions to breast-conserving surgery, hormone therapy risk awareness, and the publication of the authoritative 'Dr. Susan Love's Breast Book. 'PR NewswireSusan M. Love, MD, MBA, Chief Visionary Officer and "Founding Mother" of Breast Cancer Advocacy and Research DiesSusan M. Love, MD, founder and Chief Visionary Officer of the Dr. Susan Love Foundation for Breast Cancer Research, died on July 2, 2023, in Los Angeles at age 75 due to recurrent leukemia. She was a pioneering breast surgeon and advocate known for her work in tissue-conserving cancer surgery and establishing the National Breast Cancer Coalition. Her legacy includes significant contributions to breast cancer research, including an NIH-sponsored study on handheld ultrasound devices with AI.GlobeNewswireNBCC Honors Hillary Rodham Clinton at Annual Gala in New YorkThe National Breast Cancer Coalition will honor Hillary Rodham Clinton, Cindi Leive, and advocates Ghecemy Lopez and Wanda Lucas at its annual New York Gala on November 19. The awards recognize their leadership in breast cancer advocacy, including Clinton's role on the President's Cancer Panel and Leive's platform at Glamour.GlobeNewswireBioMarin Provides BMN 673 Program UpdateBioMarin reported a 50% RECIST response rate in its Phase 1/2 study of BMN 673 for gBRCA breast cancer, with nine of 18 patients responding. The company expects to start a Phase 3 trial in the third quarter of 2013, earlier than previously announced, and the National Breast Cancer Coalition will assist with recruitment.